Abstract:Access to a new class of indole derivatives was gained when Gray and Archer published their work on the pyridylethylation of indoles.1 The usefulness of this general reaction was enhanced by the finding that catalytic hydrogenation of indolylethylpyridines led to selective saturation of the pyridine ring.2 3 Alkylation of the resultant uidolylethylpiperidines gave products which displayed marked depressant effects on the central nervous system of mice and dogs. Certain
“…An interest in the antihypertensive activity of some so called 'Bis-indoles' (Archibald, Baum & Childress, 1970) was a prelude to the development of indoramin. These compounds were unrelated to any known antihypertensive agent and their detailed mode of action remained unknown, but a-blockade was believed to play an important part in their hypotensive effects.…”
The role of α‐blockade in the treatment of hypertension can be reappraised in the light of a recently developed agent (indoramin) which overcomes the major drawbacks of earlier agents.
The medicinal chemistry involved in the discovery and synthesis of indoramin is summarized.
Highlights of the animal pharmacology of indoramin are outlined with reference to therapeutic utility as an antihypertensive agent.
The mode of action of indoramin can be described as competitive post‐synaptic α‐adrenoceptor antagonism combined with myocardial membrane stabilization.
Indoramin is an effective antihypertensive agent in man, without therapeutic problems associated with tachycardia, postural hypotension, tolerance, poor absorption, gastrointestinal disturbances, increased peripheral resistance or increased airways resistance. The pre‐clinical basis for these features has been reviewed.
“…An interest in the antihypertensive activity of some so called 'Bis-indoles' (Archibald, Baum & Childress, 1970) was a prelude to the development of indoramin. These compounds were unrelated to any known antihypertensive agent and their detailed mode of action remained unknown, but a-blockade was believed to play an important part in their hypotensive effects.…”
The role of α‐blockade in the treatment of hypertension can be reappraised in the light of a recently developed agent (indoramin) which overcomes the major drawbacks of earlier agents.
The medicinal chemistry involved in the discovery and synthesis of indoramin is summarized.
Highlights of the animal pharmacology of indoramin are outlined with reference to therapeutic utility as an antihypertensive agent.
The mode of action of indoramin can be described as competitive post‐synaptic α‐adrenoceptor antagonism combined with myocardial membrane stabilization.
Indoramin is an effective antihypertensive agent in man, without therapeutic problems associated with tachycardia, postural hypotension, tolerance, poor absorption, gastrointestinal disturbances, increased peripheral resistance or increased airways resistance. The pre‐clinical basis for these features has been reviewed.
“…Compounds 4 – 9 were prepared by heating the appropriately substituted indole with either 2-vinylpyridine (for 4 – 6 ) or 4-vinylpyridine (for 7 – 9 ) in acetic acid as described previously [ [12] , [13] , [14] , [15] ]. Similar reactions [ 13 ] between 2-chloro-4-vinylpyrimidine [ 16 ] in a mixture of acetic acid and 1,4-dioxane afforded 11 – 13 .…”
“…1.4-Bis(3-indoleglyoxyloyl)piperazine (1). Piperazine (2.6 g, 30 mmol) in dry 1,2-DME (100 ml) was stirred while 3-indoleglyoxyloyl chloride (4.3 g, 20 mmol) in 1,2-DME (25 ml) was added dropwise.…”
Section: Methodsmentioning
confidence: 99%
“…Theoretical Method. The same postulate as in part 1 is made; i.e., the rate of biological response is expressed in the simple form d(biological response) _ At AC x p3i (Brownian) x p*2 (binding) (1) where C is the drug concentration, p(Brownian) is the probability of successful penetration of a drug molecule in the Brownian-like motion (see Figure 1) through biomembranes to reach a receptor, p(binding) is the probability of a successful binding between a drug molecule and a receptor, and al and a2 are constants.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.